Marker Therapeutics, Inc.

Tagged: multi-antigen

Marker Therapeutics to Present at the 2019 BIO CEO & Investor Conference

Chief Financial Officer, Anthony H. Kim, to present a corporate overview at the upcoming BIO CEO & Investor Conference on Monday, February 11, 2019.

Read More

Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019

Peter L. Hoang to present a corporate overview at the upcoming Phacilitate Leaders World & World Stem Cell Summit 2019 on January 23, 2019.

Read More